138 related articles for article (PubMed ID: 15905495)
1. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant.
Orabona C; Belladonna ML; Vacca C; Bianchi R; Fallarino F; Volpi C; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
J Immunol; 2005 Jun; 174(11):6582-6. PubMed ID: 15905495
[TBL] [Abstract][Full Text] [Related]
2. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
Orabona C; Pallotta MT; Volpi C; Fallarino F; Vacca C; Bianchi R; Belladonna ML; Fioretti MC; Grohmann U; Puccetti P
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20828-33. PubMed ID: 19088199
[TBL] [Abstract][Full Text] [Related]
3. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells.
Fallarino F; Orabona C; Vacca C; Bianchi R; Gizzi S; Asselin-Paturel C; Fioretti MC; Trinchieri G; Grohmann U; Puccetti P
Int Immunol; 2005 Nov; 17(11):1429-38. PubMed ID: 16172135
[TBL] [Abstract][Full Text] [Related]
4. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
Munn DH; Sharma MD; Mellor AL
J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
[TBL] [Abstract][Full Text] [Related]
5. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4-Ig regulates tryptophan catabolism in vivo.
Grohmann U; Orabona C; Fallarino F; Vacca C; Calcinaro F; Falorni A; Candeloro P; Belladonna ML; Bianchi R; Fioretti MC; Puccetti P
Nat Immunol; 2002 Nov; 3(11):1097-101. PubMed ID: 12368911
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice.
Fallarino F; Bianchi R; Orabona C; Vacca C; Belladonna ML; Fioretti MC; Serreze DV; Grohmann U; Puccetti P
J Exp Med; 2004 Oct; 200(8):1051-62. PubMed ID: 15492127
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentiation of the CD8 alpha+ subset.
Grohmann U; Bianchi R; Belladonna ML; Silla S; Fallarino F; Fioretti MC; Puccetti P
J Immunol; 2000 Aug; 165(3):1357-63. PubMed ID: 10903738
[TBL] [Abstract][Full Text] [Related]
9. CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig.
Vacca C; Fallarino F; Perruccio K; Orabona C; Bianchi R; Gizzi S; Velardi A; Fioretti MC; Puccetti P; Grohmann U
Microbes Infect; 2005 Jun; 7(7-8):1040-8. PubMed ID: 15925532
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.
Belladonna ML; Grohmann U; Guidetti P; Volpi C; Bianchi R; Fioretti MC; Schwarcz R; Fallarino F; Puccetti P
J Immunol; 2006 Jul; 177(1):130-7. PubMed ID: 16785507
[TBL] [Abstract][Full Text] [Related]
11. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
12. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
13. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement.
Fallarino F; Asselin-Paturel C; Vacca C; Bianchi R; Gizzi S; Fioretti MC; Trinchieri G; Grohmann U; Puccetti P
J Immunol; 2004 Sep; 173(6):3748-54. PubMed ID: 15356121
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of CTLA-4-Ig in tolerance induction.
Alegre ML; Fallarino F
Curr Pharm Des; 2006; 12(2):149-60. PubMed ID: 16454732
[TBL] [Abstract][Full Text] [Related]
16. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.
Grohmann U; Bianchi R; Orabona C; Fallarino F; Vacca C; Micheletti A; Fioretti MC; Puccetti P
J Immunol; 2003 Sep; 171(5):2581-7. PubMed ID: 12928409
[TBL] [Abstract][Full Text] [Related]
17. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase.
Grohmann U; Fallarino F; Bianchi R; Belladonna ML; Vacca C; Orabona C; Uyttenhove C; Fioretti MC; Puccetti P
J Immunol; 2001 Jul; 167(2):708-14. PubMed ID: 11441074
[TBL] [Abstract][Full Text] [Related]
18. When ligand becomes receptor--tolerance via B7 signaling on DCs.
Finger EB; Bluestone JA
Nat Immunol; 2002 Nov; 3(11):1056-7. PubMed ID: 12407416
[No Abstract] [Full Text] [Related]
19. Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy.
Maazi H; Shirinbak S; den Boef LE; Fallarino F; Volpi C; Nawijn MC; van Oosterhout AJ
Clin Exp Immunol; 2013 Apr; 172(1):113-20. PubMed ID: 23480191
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation.
Gonzalo JA; Delaney T; Corcoran J; Goodearl A; Gutierrez-Ramos JC; Coyle AJ
J Immunol; 2001 Jan; 166(1):1-5. PubMed ID: 11123268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
